TRIMTECH Therapeutics, a biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, today announced the closing of its $31 million (£25 million) seed funding round.
International Women's Day is a day to honour the incredible accomplishments women have made across all industries. Olivia Friett, editor of European Pharmaceutical Manufacturer, shares insights from women leaders in pharma.
Cold Chain Technologies, a global provider of advanced thermal packaging and digital monitoring solutions for the transportation of temperature-sensitive life sciences products, has announced it has acquired Global Cold Chain Solutions.
Beckman Coulter Life Sciences in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the capabilities of flow cytometry to clinical molecular research.
Centauri Therapeutics (Centauri), an immunotherapy company with a proprietary platform technology applicable across a wide range of therapeutic indications, has announced the selection of its first clinical candidate in the ABX-01 programme.
New research has revealed up to 70,000 additional jobs will be needed in the UK life sciences sector over the coming decade, if recent growth trends continue.
Milan Libánský, marketing specialist at Quinta-Analytica, discusses anaemia, a serious medical condition affecting millions of people worldwide, characterised by a lack of healthy red blood cells to carry adequate oxygen to the body's tissues.
Global contract manufacturing organisation (CMO) Symbiosis Pharmaceutical Services has completed its latest inspection by the US Food and Drug Administration (FDA) of its facilities in Scotland.
Novo Holdings and TA Associates, has announced that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites.
